Terms: = Cervical cancer AND MUC16, CA125, CA-125 AND Staging
27 results:
1. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
2. Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
Toprak S; Sahin EA; Sahin H; Tohma YA; Yilmaz E; Meydanli MM
Int J Gynaecol Obstet; 2021 Apr; 153(1):51-55. PubMed ID: 33118165
[TBL] [Abstract] [Full Text] [Related]
3. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
[TBL] [Abstract] [Full Text] [Related]
4. cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study.
Li M; Wu S; Xie Y; Zhang X; Wang Z; Zhu Y; Yan S
World J Surg Oncol; 2019 Nov; 17(1):193. PubMed ID: 31733657
[TBL] [Abstract] [Full Text] [Related]
5. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract] [Full Text] [Related]
6. Preoperative ca125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion.
Zhou X; Wang H; Wang X
J Gynecol Oncol; 2017 Mar; 28(2):e11. PubMed ID: 27894164
[TBL] [Abstract] [Full Text] [Related]
7. Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study.
Boyraz G; Salman MC; Basaran D; Ozgul N; Turan T; Turkmen O; Kimyon GC; Ozkan NT; Cagan M; Gungor T; Meydanli MM; Gungorduk K; Gulseren V; Sanci M; Yuce K
Int J Gynecol Cancer; 2017 Jan; 27(1):102-108. PubMed ID: 27668395
[TBL] [Abstract] [Full Text] [Related]
8. Computed tomography as a predictor of the extent of the disease and surgical outcomes in ovarian cancer.
Cerci ZC; Sakarya DK; Yetimalar MH; Bezircioglu I; Kasap B; Baser E; Yucel K
Ginekol Pol; 2016; 87(5):326-32. PubMed ID: 27304646
[TBL] [Abstract] [Full Text] [Related]
9. Tumor Diameter for Prediction of Recurrence, Disease Free and Overall Survival in Endometrial cancer Cases.
Senol T; Polat M; Ozkaya E; Karateke A
Asian Pac J Cancer Prev; 2015; 16(17):7463-6. PubMed ID: 26625745
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative Pelvic MRI and Serum cancer Antigen-125: Selecting Women With Grade 1 Endometrial cancer for Lymphadenectomy.
Sadowski EA; Robbins JB; Guite K; Patel-Lippmann K; Munoz del Rio A; Kushner DM; Al-Niaimi A
AJR Am J Roentgenol; 2015 Nov; 205(5):W556-64. PubMed ID: 26496578
[TBL] [Abstract] [Full Text] [Related]
11. Gynecologic oncologic imaging with PET/CT.
Grant P; Sakellis C; Jacene HA
Semin Nucl Med; 2014; 44(6):461-78. PubMed ID: 25362236
[TBL] [Abstract] [Full Text] [Related]
12. HE4 and ca125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
[TBL] [Abstract] [Full Text] [Related]
13. [Gynecology].
Petignat P; Achtari C
Rev Med Suisse; 2010 Jan; 6(232):105-8. PubMed ID: 20170026
[TBL] [Abstract] [Full Text] [Related]
14. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
[TBL] [Abstract] [Full Text] [Related]
15. PET and PET-CT imaging of gynecological malignancies: present role and future promise.
Basu S; Li G; Alavi A
Expert Rev Anticancer Ther; 2009 Jan; 9(1):75-96. PubMed ID: 19105709
[TBL] [Abstract] [Full Text] [Related]
16. Staining characterization by immunohistochemistry of tumor cancer antigen in patients with endometrial cancer.
Metindir J; Dilek GB; Pak I
Eur J Gynaecol Oncol; 2008; 29(5):489-92. PubMed ID: 19051819
[TBL] [Abstract] [Full Text] [Related]
17. Unusual presentation of cervical cancer as advanced ovarian cancer.
Abdulhathi MB; Al-Salam S; Kassis A; Ghazal-Aswad S
Arch Gynecol Obstet; 2007 Oct; 276(4):387-90. PubMed ID: 17440746
[TBL] [Abstract] [Full Text] [Related]
18. Supracervical hysterectomy in patients with advanced epithelial ovarian cancer.
Milam MR; Sood AK; King S; Bassett RL; Lu KH; Slomovitz BM; Coleman RL; Ramirez PT
Obstet Gynecol; 2007 Mar; 109(3):641-6. PubMed ID: 17329515
[TBL] [Abstract] [Full Text] [Related]
19. Positron emission tomography imaging for gynecologic malignancy.
Lai CH; Yen TC; Chang TC
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):37-41. PubMed ID: 17218850
[TBL] [Abstract] [Full Text] [Related]
20. Clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grade.
Dvalishvili I; Charkviani L; Turashvili G; Burkadze G
Georgian Med News; 2006 Mar; (132):24-7. PubMed ID: 16636372
[TBL] [Abstract] [Full Text] [Related]
[Next]
